HomeAI · summaries
Storia in 4 fonti
Wall Street May Be Mispricing Medtronic, Analyst Says - Medtronic (NYSE:MDT)
BTIG upgrades Medtronic (MDT) to Buy with a $90 target after a strong Q4 revenue beat and accelerating organic growth. Read more.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
benzinga.com
Medtronic to Report Fiscal Fourth Quarter Results; These Most Accurate Analysts Revise Forecasts Ahead Of
Medtronic (MDT) to report Q4 2026 results on 6/3, expected revenue of $9.61B & EPS of $1.55. Recent acquisition of SPR Therapeutics adds to neuromodulation business. Analyst…
- ·
How To Earn $500 A Month From Medtronic Stock After Q4 Earnings - Medtronic (NYSE:MDT)
Medtronic to report Q4 2026 results with expected revenue of $9.61B and EPS of $1.55. Dividend yield is 3.83%.
- ·
morningstar.com
Medtronic Up Nearly 5%, on Pace for Largest Percent Increase Since November 2020 — Data Talk
Medtronic Plc (MDT) is currently at $77.42, up $3.67 or 4.98%
- ·
irishtimes.com
Medtronic beats quarterly estimates on robust demand for heart devices
Irish-headquartered medtech giant working through spin out of diabetes business and focus on smaller, targeted acquisitions
- ·
Why Is Medtronic Stock Gaining Wednesday? - Medtronic (NYSE:MDT)
Medtronic (MDT) stock jumps after beating Q4 revenue expectations, driven by strong growth in cardiovascular and diabetes tech.
- ·
Wall Street May Be Mispricing Medtronic, Analyst Says - Medtronic (NYSE:MDT)
BTIG upgrades Medtronic (MDT) to Buy with a $90 target after a strong Q4 revenue beat and accelerating organic growth. Read more.
- ·
markets.businessinsider.com
J.P. Morgan Reaffirms Their Hold Rating on Medtronic (MDT)
J.P. Morgan analyst Robbie Marcus maintained a Hold rating on Medtronic yesterday and set a price target of $86.00. The company’s shares closed ...